Affordable Access

Publisher Website

Steady-dose and escalating-dose “binge” administration of cocaine alter expression of behavioral stereotypy and striatal preprodynorphin mRNA levels in rats

Brain Research Bulletin
Publication Date
DOI: 10.1016/j.brainresbull.2005.04.018
  • Cocaine
  • Dose
  • Striatum
  • Dynorphin
  • Behavior


Abstract This study examined the effects of chronic (14-day) steady-dose and escalating-dose “binge” pattern cocaine administration on striatal preprodynorphin (ppDyn) mRNA levels and behavioral stereotypies. Animals in the steady-state and escalating groups received cocaine in a “binge” pattern (three equal injections starting 30 min following the start of the daily light cycle, separated by 1 h). The dose of cocaine in the “steady-dose” group was 15 mg/kg/injection and remained constant throughout the study. The escalating group received 15 mg/kg/injection on days 1–3, 20 mg/kg/injection on days 4–6, 25 mg/kg/injection on days 7–9 and 30 mg/kg/injection thereafter, for a maximum daily dose of 90 mg/kg. Levels of ppDyn mRNA were determined by solution hybridization. Cocaine significantly affected body weight. Both steady-dose and escalating-dose “binge” cocaine administration resulted in expression of behavioral stereotypy and induced intense, rapid head movements which were dose- and time-dependent. Cocaine, independent of dose, increased ppDyn mRNA levels in the caudate putamen (CPu), but not in the nucleus accumbens (NAc). These data suggest that the ppDyn response to cocaine in the CPu is not dose-dependent or that it has reached a maximal level at the 45 mg/kg daily dose.

There are no comments yet on this publication. Be the first to share your thoughts.